SCHEMBL18544740

SCHEMBL18544740

CC1COC2(CCC(O)(c3nccs3)CC2)O1

nearest known ligand 0.40

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
OPRL1 P41146 1/20 0.40
BACE1 P56817 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL743084 0.78 OPRL1 (0.46) OPRL1
SCHEMBL17151565 0.73 OPRL1 (0.47) OPRL1BACE1
SCHEMBL25555029 0.73 SLC6A2 (0.43) OPRL1
SCHEMBL1356638 0.70 OPRL1 (0.53) OPRL1
SCHEMBL9049881 0.70 OPRL1 (0.49) OPRL1BACE1
SCHEMBL2042478 0.69 OPRL1 (0.51) OPRL1
Alcohol SCHEMBL6978627 0.67 OPRL1 (0.47) OPRL1
SCHEMBL13229274 0.67 OPRL1 (0.57) OPRL1
SCHEMBL1355838 0.67 OPRL1 (0.40) OPRL1BACE1
SCHEMBL12776380 0.67 NPC1 (0.46) OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170050942-A1 3-CYCLOALKYLAMINOPYRROLIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTORS INCYTE CORP (US) 2017-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050942-A1 3-CYCLOALKYLAMINOPYRROLIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTORS CCR2, CCR5, CXCR3 OPRL1 242/4885BACE1 3997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.